Sinem Özlem Enginler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sinem Özlem Enginler has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Sabuncu
Department of Obstetrics and Gynecology, Department of Food Hygiene and Technology, Faculty of Veterinary Medicine, Istanbul University-Cerrahpaşa , Avcilar , Türkiye
1 shared publication - Alper Baran
İstanbul University-Cerrahpasa, Faculty of Veterinary Medicine, Department of Reproduction and Artificial Insemination
1 shared publication - Asiye Izem Sandal
Department of Reprodution and Artificial Insemination Faculty of Veterinary Medicine Istanbul University‐Cerrahpaşa Istanbul Turkey
1 shared publication - Aslihan Baykal
Department of Obstetrics and Gynecology, Faculty of Veterinary Medicine İstanbul University‐Cerrahpaşa İstanbul Türkiye
1 shared publication - Atila Ateş
Department of Biochemistry, Faculty of Veterinary Medicine, İstanbul University-Cerrahpaşa
1 shared publication - Baran Çeli̇k
Department of Microbiology, Istanbul University-Cerrahpaşa, Faculty of Veterinary Medicine , Buyukcekmece , Türkiye
1 shared publication
Latest Publications
- Open Access
- 30 March 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (3) , e70924
Association of Milk C‐Reactive Protein With Subclinical Mastitis in Dairy Buffaloes
Background: Subclinical mastitis is the predominant form of mammary inflammation in dairy buffaloes and remains a diagnostic challenge under field conditions. Objectives: This study assessed milk C‐reactive protein (CRP) concentrations in relation to somatic cell count (SCC) and microbiological findings in Anatolian and Italian Mediterranean buffaloes. Methods: Milk samples were collected from 160 individual mammary lobes and classified as subclinical mastitis‐positive or healthy based on combined cytological and bacteriological criteria. SCC was determined using an automated cell counter, microbiological examination was performed by conventional culture and identification methods, and milk CRP concentrations were quantified by a sandwich ELISA. Results: SCC was significantly higher in subclinical mastitis‐affected mammary lobes than in healthy controls in both breeds ( p < 0.001). Mean SCC values were 1616.05 ± 167.04 ×10 3 cells/mL and 1245.98 ± 82.90 ×10 3 cells/mL in subclinical mastitis samples from Anatolian Mediterranean and Italian Mediterranean buffaloes, respectively, whereas corresponding control values were 285.48 ± 19.96 ×10 3 cells/mL and 254.45 ± 21.44 ×10 3 cells/mL ( p < 0.001). Bacterial growth was detected only in samples classified as subclinical mastitis, with Staphylococcus aureus identified as the most frequent isolate. Mean milk CRP concentrations were significantly higher in subclinical mastitis samples compared with controls, with values of 196.26 ± 3.44 ng/mL and 205.45 ± 5.89 ng/mL in subclinical mastitis samples from Anatolian Mediterranean and Italian Mediterranean buffaloes, respectively, versus 162.16 ± 4.95 ng/mL and 158.22 ± 3.32 ng/mL in control samples ( p < 0.001). Breed did not influence milk CRP concentrations within the same mastitis status. Conclusions: These results indicate that milk CRP reflects mammary inflammatory activity and provides information complementary to SCC in the evaluation of subclinical mastitis in dairy buffaloes.
- 30 March 2026
- Published by Wiley in Veterinary Medicine and Science
- Vol. 12 (3) , e70924
Open AccessAssociation of Milk C‐Reactive Protein With Subclinical Mastitis in Dairy Buffaloes
Background: Subclinical mastitis is the predominant form of mammary inflammation in dairy buffaloes and remains a diagnostic challenge under field conditions. Objectives: This study assessed milk C‐reactive protein (CRP) concentrations in relation to somatic cell count (SCC) and microbiological findings in Anatolian and Italian Mediterranean buffaloes. Methods: Milk samples were collected from 160 individual mammary lobes and classified as subclinical mastitis‐positive or healthy based on combined cytological and bacteriological criteria. SCC was determined using an automated cell counter, microbiological examination was performed by conventional culture and identification methods, and milk CRP concentrations were quantified by a sandwich ELISA. Results: SCC was significantly higher in subclinical mastitis‐affected mammary lobes than in healthy controls in both breeds ( p < 0.001). Mean SCC values were 1616.05 ± 167.04 ×10 3 cells/mL and 1245.98 ± 82.90 ×10 3 cells/mL in subclinical mastitis samples from Anatolian Mediterranean and Italian Mediterranean buffaloes, respectively, whereas corresponding control values were 285.48 ± 19.96 ×10 3 cells/mL and 254.45 ± 21.44 ×10 3 cells/mL ( p < 0.001). Bacterial growth was detected only in samples classified as subclinical mastitis, with Staphylococcus aureus identified as the most frequent isolate. Mean milk CRP concentrations were significantly higher in subclinical mastitis samples compared with controls, with values of 196.26 ± 3.44 ng/mL and 205.45 ± 5.89 ng/mL in subclinical mastitis samples from Anatolian Mediterranean and Italian Mediterranean buffaloes, respectively, versus 162.16 ± 4.95 ng/mL and 158.22 ± 3.32 ng/mL in control samples ( p < 0.001). Breed did not influence milk CRP concentrations within the same mastitis status. Conclusions: These results indicate that milk CRP reflects mammary inflammatory activity and provides information complementary to SCC in the evaluation of subclinical mastitis in dairy buffaloes.
- 19 February 2025
- Published by Taylor & Francis
- p. 254-271
Embedded Systems in Developing Advanced Strategies in Healthcare Management
This chapter highlights the complicated issue of embedded systems and underlines the significant effect they have had on various areas of biotechnology and healthcare. It covers a wide range of issues, such as how embedded systems are essential to advanced medical technology and how they are used to generate novel strategies. Studies are conducted on the potential of improving medical evaluations and treatments at the meeting point of deep learning and embedded image processing. Moreover, highlighted is the combination of embedded systems with the Internet of Intelligent Things, focusing on the consequences for outcomes. The topic of medical imaging analysis is further investigated, with recent developments and effects for therapy efficacy and diagnosis accuracy presented. Furthermore, the analysis of the integration of artificial intelligence-based systems and machine learning in biotechnological applications reveals new directions in the discovery of drugs, customized treatment, and bioprocess control. This chapter emphasizes the vital function that embedded systems will have in determining the direction of bioscience and healthcare in the future through a thorough synthesis of these issues.
- 19 February 2025
- Published by Taylor & Francis
- p. 254-271
Embedded Systems in Developing Advanced Strategies in Healthcare Management
This chapter highlights the complicated issue of embedded systems and underlines the significant effect they have had on various areas of biotechnology and healthcare. It covers a wide range of issues, such as how embedded systems are essential to advanced medical technology and how they are used to generate novel strategies. Studies are conducted on the potential of improving medical evaluations and treatments at the meeting point of deep learning and embedded image processing. Moreover, highlighted is the combination of embedded systems with the Internet of Intelligent Things, focusing on the consequences for outcomes. The topic of medical imaging analysis is further investigated, with recent developments and effects for therapy efficacy and diagnosis accuracy presented. Furthermore, the analysis of the integration of artificial intelligence-based systems and machine learning in biotechnological applications reveals new directions in the discovery of drugs, customized treatment, and bioprocess control. This chapter emphasizes the vital function that embedded systems will have in determining the direction of bioscience and healthcare in the future through a thorough synthesis of these issues.
- Open Access
- 25 December 2020
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 68 (1) , 33-38
Improvement of bovine in vitro embryo production by fetal calf serum and cysteamine supplementation and investigation of freezability
The aim of this study was to investigate the effects of Cysteamine (Cys) and Fetal Calf Serum (FCS) in Synthetic Oviduct Fluid (SOF) and Charles and Rosenkrans (CR1aa) on the bovine in vitro embryo production and its ability of freeze. The oocytes were divided into two groups and allowed to mature in TCM-199, with and without cysteamine. They were divided into 4 subgroups according to whether they contain Cys and FCS in 2 different culture media (SOF and CR1aa). Accordingly, 8 groups were formed as SOF+FCS+Cys, SOF+Cys, SOF+FCS, S Dulbeco's OF, CR1aa+FCS+Cys, CR1aa+Cys, CR1aa+FCS and CR1aa. Embryos were cultured for 7-9 days and were frozen using vitrification method. Development of embryos was observed during the first 24 hr post-thaw period. The highest rate of compact morula was 20% in SOF+FCS+Cys and 19.4% in CR1aa+FCS+Cys. The rate of blastocyst in SOF+FCS and CR1aa+FCS were found 17.9% and 15.4% respectively and the difference between groups was statistically significant (P<0.05). During the 12 hr vitality assessment, the highest rate was determined in SOF+FCS (47%). The results indicate that FCS has a positive effect in reaching compact morula and blastocyst regardless of the presence of the culture medium or antioxidant used. There was no statistically difference between the values of post-thaw embryos.
- 25 December 2020
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 68 (1) , 33-38
Open AccessImprovement of bovine in vitro embryo production by fetal calf serum and cysteamine supplementation and investigation of freezability
The aim of this study was to investigate the effects of Cysteamine (Cys) and Fetal Calf Serum (FCS) in Synthetic Oviduct Fluid (SOF) and Charles and Rosenkrans (CR1aa) on the bovine in vitro embryo production and its ability of freeze. The oocytes were divided into two groups and allowed to mature in TCM-199, with and without cysteamine. They were divided into 4 subgroups according to whether they contain Cys and FCS in 2 different culture media (SOF and CR1aa). Accordingly, 8 groups were formed as SOF+FCS+Cys, SOF+Cys, SOF+FCS, S Dulbeco's OF, CR1aa+FCS+Cys, CR1aa+Cys, CR1aa+FCS and CR1aa. Embryos were cultured for 7-9 days and were frozen using vitrification method. Development of embryos was observed during the first 24 hr post-thaw period. The highest rate of compact morula was 20% in SOF+FCS+Cys and 19.4% in CR1aa+FCS+Cys. The rate of blastocyst in SOF+FCS and CR1aa+FCS were found 17.9% and 15.4% respectively and the difference between groups was statistically significant (P<0.05). During the 12 hr vitality assessment, the highest rate was determined in SOF+FCS (47%). The results indicate that FCS has a positive effect in reaching compact morula and blastocyst regardless of the presence of the culture medium or antioxidant used. There was no statistically difference between the values of post-thaw embryos.